Page last updated: 2024-11-12

yw 3548

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

YW 3548: inhibits glycosylphosphatidylinositol synthesis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

YW3548 : A terpene lactone that is obtained from Codinea simplex and acts as an inhibitor of glycerophosphoinositol biosynthesis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9916153
CHEMBL ID4787144
CHEBI ID79385
MeSH IDM0284230

Synonyms (8)

Synonym
CHEBI:79385
yw-3548
yw3548
(1r,4r,4ar,6z,7ar,8ar,10s,11s,11ar,12ar,13ar)-1,13a-dihydroxy-11-isopropyl-4,7,8a-trimethyl-13-methylene-2-oxo-1,2,4,4a,5,7a,8,8a,9,10,11,11a,12,12a,13,13a-hexadecahydroindeno[5',6':4,5]cycloocta[1,2-c]pyran-10-yl 3-hydroxy-3,5-dimethylheptanoate
yw 3548
[(1r,3r,4r,7r,8r,10z,12r,14r,16s,17s,18r)-3,4-dihydroxy-7,11,14-trimethyl-2-methylidene-5-oxo-17-propan-2-yl-6-oxatetracyclo[10.7.0.03,8.014,18]nonadec-10-en-16-yl] 3-hydroxy-3,5-dimethylheptanoate
Q27148428
CHEMBL4787144
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
glycerophosphoinositol synthesis inhibitorA pathway inhibitor that disrupts the synthesis of glycerophosphoinositol
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
terpene lactone
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1717676Antifungal activity against Candida krusei ATCC 6258 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717673Antifungal activity against Candida lusitaniae MY1396 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717670Antifungal activity against Candida albicans Ca2323/ORF6.945 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717675Antifungal activity against Aspergillus fumigatus MF5668 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717671Antifungal activity against Candida albicans Ca1055 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717674Antifungal activity against Candida glabrata MY1381 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717672Antifungal activity against Candida parapsilosis ATCC22019 by CLSI method2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]